MCI
48
14
17
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 48 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
12%
2 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (48)
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Ketogenic Diet to Reduce Osteoarthritis Pain in MCI
Accexible Speech Analysis for MCI Detection and Monitoring in Colombia
FACE Phase II (a Stage II Trial)
Impact of Nutrition, Sleep, and Physical Activity on Intellectual Function and Muscle Mass in Older Adults
Telehealth-Adapted Compensatory Training and Intervention for Cognition
Cognitive-Motor Training for AD/ADRD Prevention
Enhancing Attention and Wellbeing Using Digital Therapeutics
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
Accelerating Cognitive Gains From Digital Inverventions With Noninvasive Brain Stimulation
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
Neurocognitive Assessment Platform 4 Alzheimer
Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.
Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
Tau PET Imaging in the NACC Study Cohort
Neuromodulation of Memory in Aging
Cognitive Therapy Software for Improving Cognitive Function for Patients With Mild Cognitive Impairment
Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI)
A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection
BRain Energy Activation With Ketones to Prevent Alzheimer's Disease